Impact of Poorly Controlled Hypertension on Healthcare Resource Utilization and CostByL. Clark Paramore, MSPH,Michael T. Halpern, MD, PhD,Pablo Lapuerta, MD,Judith S. Hurley, MS, RD,Floyd J. Frost, PhD,David G. Fairchild, MD, MPHApril 1st 2001
A Pharmacoeconomic Analysis of Rimelolone for the Treatment of Ophthalmic Inflammatory ConditionsByMichael T. Halpern, MD, PhD,Cynthia S. Palmer, MSc,C. Stephen Foster, MD,Ashish Pal, BS Pharm, MBA,Carmelina Battista, PharmDJune 1st 1998
Modeling the Cost-Effectiveness of Oral Therapy for Nail FungusByMichael T. Halpern, MD, PhD,Cynthia Palmer, MScJanuary 1st 1996
Modeling the Cost-Effectiveness of Oral Therapy for Nail Fungus